Palatin Technologies Added to Russell 3000® Index
Jun 25, 2018, 04:56 ET CRANBURY, N.J., June 25, 2018 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced that it has been added to the Russell 3000® Index as part of the annual …
Palatin Technologies Added to Russell 3000® Index Read More »